Literature DB >> 2041678

Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin.

J Alonso, V Madrigal, M García-Fuentes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041678     DOI: 10.1097/00006454-199103000-00022

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

Review 1.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

2.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  M M París; S Shelton; M Trujillo; S M Hickey; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

3.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M I Uscher; S Shelton; K D Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

5.  Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong.

Authors:  K M Kam; K Y Luey; S M Fung; P P Yiu; T J Harden; M M Cheung
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 6.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.